Morning
10:00 – 10:30 | Registration and Coffee | |
10:30 – 10:35 | Welcome and Introduction | Professor Neil Poulter and Professor Kausik Ray, Imperial College London |
10:35 – 11:00 | CVD prevention in DM – The importance of BP lowering | Professor Neil Poulter Imperial College London |
11:00 – 11:30 | The role of SGLT2s: Trial evidence and future prospects | Professor Kausik Ray Imperial College London |
11:30 – 12:00 | The role of GLP1-As: Trial evidence and future prospects | Professor Miles Fisher Glasgow Royal Infirmary |
12:00 – 12:30 | The role of other glucose lowering therapies: Trial evidence and future prospects | Professor Clifford J Bailey Aston University |
12:30 – 13:00 | Renal outcomes in glucose-lowering trials | Professor David Wheeler University College London |
13:00 – 13:40 | Lunch |
Afternoon
13:40 – 14:10 | Hypoglycaemia and CVD | Dr Mark Evans University of Cambridge |
14:10 – 14:30 | Breakout groups (8-10 people per group)
a. Treatment pathway for optimising 2ry prevention of CV events in T2DM |
|
14:30 – 15:15 | Groups Feedback | |
15:15 – 15:45 | Heart failure and T2DM | Professor Theresa A McDonagh King’s College London |
15:45 – 16:15 | Lipid lowering for optimal CVD prevention | Professor Kausik Ray Imperial College London |
16:15 – 17:00 | Keynote lecture Cardiometabolic disease: burden and management |
Professor David Wood Imperial College London |
17:00 – 18:00 | Close of meeting and refreshments |
*Please note, this Programme is correct as of 14.09.18 and is subject to changes.
Find out more
About the Meeting
We explored the latest techniques and developments in cardio-metabolic science.
Programme
The invited faculty delivered an innovative, comprehensive and educational programme.
Location
The Meeting took place at Imperial College's Translation and Innovation Hub.